Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Comparative effectiveness research
Scholarly Publications
Anesthesia Care Team Composition and Surgical Outcomes
August 2018
The adjusted mortality for care teams with anesthesiologist assistants was 1.6% (95% CI, 1.4 to 1.8) versus 1.7% for care teams with nurse anesthetists (95% CI, 1.7 to 1.7; difference −0.08; 95% CI...
Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India
August 2018
The decreasing effectiveness of antimicrobial agents is a global public health threat, yet risk factors for community-acquired antimicrobial resistance (CA-AMR) in low-income settings have not been...
ACA Marketplace Premiums and Competition Among Hospitals and Physician Practices
July 2018
In this study published in the American Journal of Managed Care, the authors found that premiums for ACA Marketplace plans were higher in rating areas in which physician, hospital, and insurance...
Other Publications
Comparative Effectiveness Research Prioritization
June 2009
Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options.
Maternal and Neonatal Outcomes of Elective Induction of Labor
March 2009
Background: Induction of labor is on the rise in the U.S., increasing from 9.5 percent in 1990 to 22.1 percent in 2004.
News
Poor, Older Americans Healthier If They Live in More Affluent Communities
September 2019
New research by Maria Polyakova shows that older, low-income Americans tend to be healthier if they live in more affluent areas of the country.
Stanford Legal Experts on the Oklahoma Opioids Verdict and Ongoing Litigation
August 2019
On August 26, Judge Thad Balkman delivered a $572 million judgment against pharmaceutical giant Johnson & Johnson for the company’s role in fueling the opioid epidemic in Oklahoma.
All Adults Should Be Tested for Hepatitis C; It Now Kills More Americans Than All Other Reportable Infectious Diseases Combined
August 2019
A task force of national health experts has released a draft recommendation to screen all adults 18 to 79 years for the hepatitis C virus (HCV), noting the opioid epidemic has fueled what has...
Events